Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Paragon Care Limited ( (AU:PGC) ) has provided an update.
Paragon Care will cease acting as the primary wholesaler to Ramsay Healthcare’s retail and hospital pharmacy operations from 1 February 2026 after its re-tender bid was undercut by a lower-priced competitor, a contract that added about A$230 million to FY25 revenue but less than 2% to gross margin. Management expects the exit to have an immaterial impact on FY26 earnings as it strips out associated supply chain costs, while the release of roughly A$4.5 million in working capital will be used to pay down debt, reinforcing a strategic focus on higher-margin business, strong underlying healthcare demand and a reported A$1.9 billion in unaudited half-year group revenue.
The most recent analyst rating on (AU:PGC) stock is a Hold with a A$0.24 price target. To see the full list of analyst forecasts on Paragon Care Limited stock, see the AU:PGC Stock Forecast page.
More about Paragon Care Limited
Paragon Care Limited is an ASX-listed Australian healthcare company that supplies medical equipment, devices, consumables, pharmaceuticals, complementary medicines, nutritional products and manufactures blood bank diagnostic reagents for healthcare markets in Australia, New Zealand and Asia.
Average Trading Volume: 998,494
Technical Sentiment Signal: Sell
Current Market Cap: A$405.5M
Find detailed analytics on PGC stock on TipRanks’ Stock Analysis page.